The company's financial position is characterized by significant capital erosion, evidenced by an accumulated deficit that reached $144.5 million as of 2026Q1.
| Total Current Assets | 8.35M | 10.06M | 2.81M | 6.67M | 6.12M | 10.66M | 4.82M | 3.54M | 6.67M | 7.87M | 12.23M | 190K | 885K |
| Cash & Short-Term Investments | 6.8M | 8.57M | 1.31M | 5.39M | 4.78M | 9.33M | 3.64M | 1.94M | 4.92M | 7.12M | 11.83M | 141K | 821K |
| Cash Only | 6.8M | 7.58M | 1.31M | 5.39M | 4.78M | 9.33M | 3.64M | 1.94M | 4.92M | 2.1M | 11.83M | 141K | 821K |
| Short-Term Investments | 0 | 994K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.02M | 0 | 0 | 0 |
| Accounts Receivable | 163K | 201K | 335K | 95K | 113K | 77K | 25K | 149K | 139K | 16K | 10K | 13K | 31K |
| Days Sales Outstanding | 52.73 | 33.03 | 65.85 | 29.07 | 40.48 | 48.79 | 35.37 | 380.31 | 170.82 | 112.31 | 11.48 | 19.69 | 56.86 |
| Inventory | 1.05M | 994K | 794K | 795K | 853K | 1M | 945K | 1.18M | 1.26M | 540K | 57K | 0 | 0 |
| Days Inventory Outstanding | 381.61 | 435.55 | 339.75 | 443.69 | 560.98 | 1.03K | 1.23K | 4.26K | 1.91K | 4.38K | 106.15 | - | - |
| Other Current Assets | 338K | 297K | 350K | 0 | 0 | 22K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 2.71M | 2.78M | 465K | 620K | 663K | 845K | 1.2M | 1.44M | 1.08M | 1.45M | 640K | 751K | 644K |
| Property, Plant & Equipment | 2.67M | 2.75M | 407K | 598K | 641K | 845K | 1.2M | 1.44M | 1.08M | 1.45M | 631K | 613K | 635K |
| Fixed Asset Turnover | 0.81x | 0.81x | 4.56x | 1.99x | 1.59x | 0.68x | 0.21x | 0.10x | 0.27x | 0.04x | 0.50x | 0.39x | 0.31x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 36K | 36K | 58K | 22K | 22K | 0 | 0 | 0 | 0 | 0 | 9K | 138K | 9K |
| Total Assets | 11.06M | 12.84M | 3.28M | 7.29M | 6.78M | 11.5M | 6.02M | 4.98M | 7.75M | 9.32M | 12.87M | 941K | 1.53M |
| Asset Turnover | 0.18x | 0.17x | 0.57x | 0.16x | 0.15x | 0.05x | 0.04x | 0.03x | 0.04x | 0.01x | 0.02x | 0.26x | 0.13x |
| Asset Growth % | 882.35% | 291.79% | -55.05% | 7.53% | -41.03% | 90.98% | 20.95% | -35.79% | -16.83% | -27.56% | 1267.69% | -38.46% | - |
| Total Current Liabilities | 938K | 798K | 561K | 786K | 1.32M | 943K | 794K | 1.58M | 1.16M | 1.17M | 1.8M | 2.21M | 4.79M |
| Accounts Payable | 115K | 183K | 215K | 150K | 540K | 333K | 404K | 265K | 173K | 391K | 351K | 544K | 151K |
| Days Payables Outstanding | 71.08 | 80.19 | 92 | 83.72 | 355.14 | 341.42 | 524.77 | 957.67 | 262.01 | 3.17K | 653.65 | - | - |
| Short-Term Debt | 205K | 200K | 56K | 33K | 0 | 32K | 98K | 123K | 219K | 189K | 75K | 689K | 2.88M |
| Deferred Revenue (Current) | 69K | 32K | 12K | 18K | 44K | 0 | 0 | 0 | 0 | 0 | 371K | 221K | 186K |
| Other Current Liabilities | 593K | 383K | 278K | 232K | 497K | 360K | 275K | 952K | 292K | 269K | 1.29M | 333K | 1.39M |
| Current Ratio | 8.91x | 12.61x | 5.01x | 8.49x | 4.62x | 11.30x | 6.07x | 2.24x | 5.74x | 6.73x | 6.81x | 0.09x | 0.18x |
| Quick Ratio | 7.79x | 11.36x | 3.60x | 7.48x | 3.98x | 10.24x | 4.88x | 1.49x | 4.65x | 6.27x | 6.77x | 0.09x | 0.18x |
| Cash Conversion Cycle | 363.26 | 388.39 | 313.6 | 389.04 | 246.32 | 733.68 | 738.09 | 3.69K | 1.82K | 1.32K | -536.02 | - | - |
| Total Non-Current Liabilities | 2.42M | 2.48M | 206K | 156K | 179K | 523K | 1.34M | 831K | 277K | 632K | 246K | 2.58M | 2.46M |
| Long-Term Debt | 2.42M | 2.48M | 206K | 156K | 0 | 0 | 646K | 137K | 261K | 591K | 144K | 484K | 277K |
| Capital Lease Obligations | 4.77M | 0 | 0 | 0 | 179K | 359K | 698K | 694K | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 164K | 0 | 0 | 16K | 41K | 102K | 2.09M | 2M |
| Total Liabilities | 3.36M | 3.27M | 767K | 942K | 1.5M | 1.47M | 2.14M | 2.41M | 1.44M | 1.8M | 2.04M | 4.79M | 7.25M |
| Total Debt | 2.63M | 2.68M | 262K | 406K | 359K | 555K | 1.44M | 954K | 480K | 780K | 219K | 1.17M | 3.16M |
| Net Debt | -4.17M | -4.9M | -1.04M | -4.99M | -4.42M | -8.77M | -2.2M | -982K | -4.44M | -1.32M | -11.61M | 1.03M | 2.34M |
| Debt / Equity | 0.34x | 0.28x | 0.10x | 0.06x | 0.07x | 0.06x | 0.37x | 0.37x | 0.08x | 0.10x | 0.02x | - | - |
| Debt / EBITDA | -0.38x | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.61x | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -324.76x | -289.14x | -280.09x | -1926.50x | -4846.50x | -750.64x | -282.46x | -237.52x | -159.92x | -141.86x | -123.08x | -20.25x | -10.39x |
| Total Equity | 7.7M | 9.57M | 2.51M | 6.35M | 5.28M | 10.04M | 3.88M | 2.57M | 6.31M | 7.52M | 10.83M | -3.85M | -5.72M |
| Equity Growth % | 782.2% | 281.04% | -60.46% | 20.31% | -47.39% | 158.37% | 51.3% | -59.34% | -16.06% | -30.53% | 381.51% | 32.81% | - |
| Book Value per Share | 1.46 | 0.29 | 3.60 | 94.81 | 1013.05 | 2152.05 | 3102.24 | 4724.38 | 15620.58 | 33060.98 | 80975.57 | -18226.43 | -27126.39 |
| Total Shareholders' Equity | 7.7M | 9.57M | 2.51M | 6.35M | 5.28M | 10.04M | 3.88M | 2.57M | 6.31M | 7.52M | 10.83M | -3.85M | -5.72M |
| Common Stock | 5K | 5K | 1K | 5K | 0 | 12K | 5K | 1K | 24K | 16K | 10K | 4K | 4K |
| Retained Earnings | -144.54M | -142.48M | -136.1M | -129.91M | -122.2M | -112.51M | -104.24M | -95.87M | -85.84M | -73.6M | -61.31M | -50.36M | -32.17M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.58M | -1.19M | -799K | 17K | -421K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Persistent equity-funded cash burn
As reported in recent financial filings, SenesTech's accumulated deficit has ballooned to $144.5 million by 2026Q1, signaling that despite periodic asset expansion, the company's fundamental trajectory remains tethered to persistent capital consumption rather than organic value creation through its specialty chemical product line and regulatory assets.
The company's trajectory is characterized by a recurring cycle of asset accumulation followed by rapid depletion, suggesting that growth is currently a function of capital raises rather than operational success. Investors should monitor whether the recent uptick in total assets can be sustained without further dilutive financing, as the current trend indicates a structural inability to reach self-funding status.
Based on the reported figures in 2026Q1, SenesTech maintains a cash balance of $7.57 million, which, when viewed against the backdrop of consistent quarterly operating losses, suggests a tightening liquidity runway that may necessitate further capital market intervention to sustain ongoing research and commercialization efforts.
While the current ratio of 8.91 appears superficially robust, it is heavily influenced by the company's specific working capital management and does not account for the high burn rate inherent in the business model. The reliance on cash reserves to fund operations implies that the company's liquidity position is highly sensitive to any delays in revenue conversion or unexpected spikes in regulatory compliance costs.
According to historical balance sheet data, the company's equity base has been consistently eroded by a massive accumulated deficit, with retained earnings reaching -$144.5 million as of 2026Q1, reflecting a long-term trend of value destruction that has necessitated frequent reliance on external equity financing to maintain operations.
The quality of equity is significantly impaired by the absence of retained earnings, which indicates that the business has yet to achieve a profitable scale. This reliance on equity financing suggests that shareholders are effectively subsidizing the company's R&D and market development, which warrants further investigation into the long-term return potential for new capital.
As evidenced by the balance sheet, the company carries zero goodwill, yet the underlying value of its EPA registrations remains unquantified, creating a potential distortion where the firm's most critical competitive advantage is not explicitly reflected in the book value of its assets, complicating traditional valuation metrics.
The absence of intangible assets on the balance sheet suggests that the company's primary moat—its regulatory exclusivity—is being expensed as incurred rather than capitalized. This accounting treatment likely contributes to the volatility in reported earnings and makes it difficult for analysts to assess the true replacement cost of the company's intellectual property portfolio.
Quick answers to the most common questions about buying SNES stock.
As of 2025, SenesTech, Inc. (SNES) had total assets of $12.8M including $10.1M in current assets.
SenesTech, Inc. (SNES) carries total debt of $2.7M, offset by $8.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
SenesTech, Inc. (SNES) has total shareholders' equity (book value) of $9.6M ($0.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.
SenesTech, Inc. (SNES) reported a current ratio of 12.61x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.